Importantly, the changes in lipid rich/necrotic plaque and calcification volumes did not reach statistical significance, unlike plaque volume, suggesting that using plaque component change as an endpoint in therapeutic trials will require greater sample size than plaque volume change.
← all excerpts
Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thickness.
1
—
—